RISK FACTOR, CARDIOVASCULAR
Clinical trials for RISK FACTOR, CARDIOVASCULAR explained in plain language.
Never miss a new study
Get alerted when new RISK FACTOR, CARDIOVASCULAR trials appear
Sign up with your email to follow new studies for RISK FACTOR, CARDIOVASCULAR, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Heart shield for chemo: new study tests carvedilol in breast cancer patients
Disease control CompletedThis early-phase study tested whether giving the heart medication carvedilol to breast cancer patients at high risk for heart problems could safely protect their hearts during chemotherapy with doxorubicin and/or trastuzumab. 68 women with stage I-III breast cancer participated. …
Matched conditions: RISK FACTOR, CARDIOVASCULAR
Phase: PHASE1 • Sponsor: Abramson Cancer Center at Penn Medicine • Aim: Disease control
Last updated May 13, 2026 15:59 UTC
-
CAR T-Cell Therapy's hidden heart risk revealed
Knowledge-focused CompletedThis study watched 44 adults with leukemia or lymphoma who were getting CAR T-cell therapy. Researchers checked their heart health before and after treatment using heart scans and blood tests. The goal was to see how often heart problems happen and who might be at higher risk.
Matched conditions: RISK FACTOR, CARDIOVASCULAR
Sponsor: Abramson Cancer Center at Penn Medicine • Aim: Knowledge-focused
Last updated May 17, 2026 07:37 UTC